Grafting of Schwann cell-seeded channels into hemisected adult rat thoracic spinal cords has been tested as a strategy to bridge the injured cord. Despite success in guiding axonal growth into the graft, regeneration across the distal graft−host interface into the host spinal cord was limited. We hypothesized that chondroitin sulfate (CS) glycoforms deposited at the gliotic front of the interface constitute a molecular barrier to axonal growth into the host cord. Because CS glycoforms deposited by purified astrocytes in vitro were removable by digestion with chondroitinase ABC, we attempted to achieve likewise by infusion of the enzyme to the host side of the interface. By 1 month post-treatment, significant numbers of regenerating axons crossed an interface that was subdued in macrophage/microglia reaction and decreased in CSimmunopositivity. The axons extended as far into the caudal cord as 5 mm, in contrast to nil in vehicle-infused controls. Fascicular organizations of axon−Schwann cell units within the regenerated tissue cable were better-preserved in enzyme-treated cords than in vehicle-infused controls. We conclude that CS glycoforms deposited during gliosis at the distal graft−host interface could be cleared by the in vivo action of chondroitinase ABC to improve prospects of axonal regeneration into the host spinal cord.
grafts (8) (9) (10) (11) have been tested as cellular implants for this purpose. Among these, grafting of SCs succeeded in promoting axonal regrowth into the graft, but appeared limiting in that few axons exit the graft. Chondroitin sulfate proteoglycans (CSPGs) are a major family of extracellular matrix molecules found up-regulated in regions of reactive gliosis after CNS injury (12) (13) (14) (15) (16) (17) (18) (19) . We hypothesized that CS glycoforms deposited during gliosis confer an axon-restrictive property at the distal graft−host interface to deter axonal crossing from the graft into the caudal host cord. Digestive removal of CS reduced growth inhibition associated with injury-induced CSPGs (12, (20) (21) (22) (23) . Therefore, in this work, we targeted CS glycoforms deposited at the distal graft−host interface by continuous infusion of chondroitinase ABC (Ch ase ABC) and found this strategy effective in allowing axons to grow from the graft into the caudal host cord, thus advancing the prospective use of SC-seeded minichannels in the practical treatment of spinal cord injuries.
MATERIALS AND METHODS

Schwann cell-seeded minichannels
Cell isolation and seeding into channels were as described by Xu and colleagues (3, 24) . Briefly, purified SCs (sciatic nerves, adult female Fischer rat) in DMEM (Gibco-BRL, Grand Island, NY): Matrigel (MG; Collaborative Research, Bedford, MA) (2:1,v/v) were drawn into a polyacrylonitrile/polyvinylchloride (PAN/PVC) copolymer channel (Dr P. Aebischer, Centre Hospitalier Universitarie Vaudois, Switzerland) and longitudinally aligned by incubation in DMEM (37°C, 16h). The channel was cut into 3-mm segments for grafting.
Enzyme infusates
Vehicle (0.2M Tris buffer, pH8 with BSA at 0.5 mg/ml) with or without Ch ase ABC (Seikagaku, Tokyo) at 5 units/ml (25) was filter-sterilized, stored at −70°C and thawed prior to use. An enzyme aliquot was kept at 37°C and sampled at defined intervals to test for action on CS (0.33mg/ml, Seikagaku); activity decay was monitored by A 232 of unsaturated disaccharide products in the mixture. To prepare for infusion, an enzyme aliquot (200µl) was loaded into the reservoir of an Alzet 2004 osmotic minipump (Alza, Palo Alto, CA) and incubated overnight in normal saline at 37°C before implantation.
Animal and tissue protocols
Procedures were as described (3, 26) and in strict accordance with the National Institute of Health Guidelines for Laboratory Animal Care and Safety. Briefly, pentobarbital-anesthetized adult female Fischer rats were laminectomized at vertebrae T7-8 to expose cord segments beneath the dura. A 2.5−2.8 mm hemicord (T8) on the right side of the animal was replaced by a 3 mm-long SC/MG minichannel with ends fitting snugly against the rostral and caudal cord stumps. The dura was closed to restore cerebrospinal fluid circulation and minimize scar invasion. After stereotaxic implantation of the infusion tip through the T9 vertebra, 1.3 mm into the thoracic cord and 0.5 mm from the distal interface, the infusate was delivered at 0.5 µl/h from the loaded minipump. Test animals (n=16) received enzyme infusion and controls (n=16) received vehicle infusion (Table 1) . A 2-ml mixture of gentamicin (0.01%) and nitrofurazone (0.05%) was injected into the subcutaneous pocket that housed the pump and then the overlying muscle layers and skin were sutured.
All operated animals had free access to autoclaved food and water in the cage. Lactated Ringer (10ml daily) and buprenex (0.1mg/100mg body weight for 3 days; Reckitt and Colman, Richmond, VA) were administered subcutaneously in the first week. Bladder expression was performed until spontaneous emptying returned. Daily weights were monitored until preoperative values were regained. After 5 weeks, animals were reanesthetized by pentobarbital and perfused with 4%formaldehyde-3%picric acid in 0.1M phosphate buffer (pH7.4) via the aorta. A 1-mm mid-graft transverse section was further fixed in 2.5%glutaraldehyde-5%sucrose in 0.1M cacodylate buffer (pH7.4) for LM and EM. Graft tissues contiguous with host spinal cords were further fixed in formaldehyde-picric acid and then transferred to 30% sucrose in 0.1M phosphate buffer (pH7.4) for immunocytochemistry.
Anterograde neuroanatomical tracing
At week 4 postgrafting, before delivery of tracer, the intact side of the host hemicord was completely transected to ensure that only axons regenerating through the graft were tracked. A solution of 1% biotinylated-dextran amine (BDA; Molecular Probes, Eugene, OR) in 0.2% PBS was then delivered by iontophoresis via a glass micropipette (10µm tip) stereotaxically positioned at 1.5mm from the dorsal cord surface and 3mm rostral to the proximal end of the guidance channel (3). After an additional week of survival, rats were perfused and horizontal cryosections (20µm) of the cord were incubated with a Vector Elite ABC kit followed by development with DAB to visualize the tracer (27) . None of the animals showed nonspecific spread of the tracer or incomplete transection of the contralateral hemicord.
Light and electron microscopy
Midgraft slices were osmicated, serially dehydrated, and then embedded in Spurr's epoxy resin. Transverse sections (1µm) were counterstained with 1% Toluidine blue in 1% borate for myelinated axon counts and blood vessel counts at a magnification of 1000× under LM (3, 24, 28) . Ultrathin sections (90nm) were contrasted with uranyl acetate and lead citrate (29) for examination under the Philips EM208S (80kV).
Immunocytochemistry
Tissues
Graft tissues contiguous with the host cords were embedded, cryosectioned (20µm), permeabilized and blocked with 0.3% Triton X-100/3% normal goat serum in 0.05M Trisbuffered saline (pH7.4) and then incubated (4°C) with primary antibodies against glial fibrillary acidic protein in astrocytes (pAb GFAP, 1:100; Biomedical Technologies, Stoughton, MA), cytoplasmic antigens in activated macrophages and microglia (mAb ED1, 1:250; Chemicon International Inc., Temecula, CA), cytoplasmic S100 protein in SCs (pAb S100, 1:100; DAKO A/S, Glostrup, Denmark), neurofilament polypeptide 200 kDa in axons (pAb NF200; 1:400; Sigma Chemical Company, St. Louis, MO), CS moiety in CSPGs (mAb CS56, 1:100; Sigma) and 4-sulfated unsaturated disaccharides of the oligosaccharide stub left on CSPG core proteins following Ch ase ABC digestion of the CS moiety (mAb 2B6, 1:100; Seikagaku), either singly or in duo. Sections were then incubated with FITC-conjugated goat anti-rabbit (1:100; Cappel, Aurora, OH) and TRITC-conjugated rabbit anti-mouse (1:100; Cappel) antibodies for examination under the fluorescence microscope (Olympus BX60). Sections tested with mAb ED1 were visualized with the use of the Vector Elite ABC method (27) . Primary antibodies were omitted in controls.
Cultured cells
Half-confluent cultures of astrocytes on poly-L-lysine and SCs on MG were fixed with 4% paraformaldehyde in 0.1M phosphate buffer (pH7.4), permeabilized in 5% acetic acid95%ethanol (4°C), and then incubated with antiGFAP/CS56 or antiS100/CS56 and relevant secondary antibodies for examination under a Zeiss laser-scanning confocal microscope.
Astrocyte culture
Cells isolated from cerebral cortices of neonatal rats (0−2 days) were cultured to confluence and then orbital-shaken (Toshiba); adherent astrocytes were replated and cultured in S-DMEM/F12 with cytosine β-D-arabinofuranoside (10µM; Sigma, St. Louis, MO) to inhibit fibroblast growth (30) . Astrocytes so prepared were 99% GFAP-positive.
SDS-PAGE and Western blot
Electrophoresis was performed in 4−20% (w/v) polyacrylamide gel, Tris-glycine buffer (pH8.3) under nonreducing conditions (0.1% SDS, 15mA, 4°C). MG samples: (1) native gel solution; (2) the gel solution acidified with acetic acid (0.2M, 30min, 4°C; total 60µl), neutralized with equimolar NaOH, and then treated with either Ch ase ABC (10units/ml, 10µl, 16h, 37°C) or buffer control. Samples were each mixed 1:1 (v/v) with 0.125M Tris-HCl (pH6.8) containing 20% glycerol and 4% SDS before application. After transfer (40V, 16h, 4°C) to PVDF (Millipore, Billerica, Mass), blots were probed with CS56 (1:400; Sigma) in TBST (20mM Tris-HCl, pH7.6, 0.9% NaCl, 0.1% Tween 20) containing 5% skim milk powder and visualized with horseradish peroxidase-conjugated with anti-mouse IgG (1:5000, BD Transduction Lab., Lexington, KY) and an ECL substrate (Amersham-Pharmacia Biotech Inc., Piscataway, NJ).
Morphometric analysis
Cryosections of the distal graft−host interface were analyzed for cavitation, the number of BDAlabeled axons, and the number of activated macrophages/microglia. The boundaries of the interface in the different sections were standardized with the use of an eyepiece graticule (grid area 475×475µm
2 ) (26). One of the grid lines was placed tangent to the distal end of the guidance channel and designated as the "zero" line; the interface zone was estimated to extend as far as 475 µm from the "zero" line. Examinations were made at a magnification of 400× under LM and values reported are as per section unless otherwise stated.
Cavitation
Cystic cavities (14) located within the interface zone were identified. The number of nonoverlapping grid subdivisions (23.75 × 23.75µm 2 ) that fell within the identified cavities was recorded for the estimation of cavitation area.
BDA-labeled axons
The BDA-labeled axons that crossed the "zero" line of the interface were counted as regrowing axons that crossed the graft−host interface into the caudal host cord. The BDA-labeled axons were also mapped beyond the interface zone to record the furthest extent reached by regrowing axons in the caudal host cord (26) .
Activated macrophages/microglia
The number of ED1-positive cells located within the interface zone was recorded.
Statistical analysis
Differences between groups were evaluated by one-way ANOVA (ANOVA) and if significant (P<0.05), were analyzed further with the Student's t-test (INSTAT v2.04a program, GraphPad Software). All statistical tests were two-tailed.
RESULTS
At the distal graft−host interface
ChaseABC infusion cleared away CS56-positive deposits
By the end of the 5th week of grafting and infusion, a fuzzy CS56-positive deposit was observable at the distal graft−host interface of vehicle-infused controls (Fig. 1A) . Double immunofluorescence revealed that the fuzzy margin was also weakly GFAP-positive, in contrast to the strongly GFAP-positive front of reactive astrocytes (Fig. 1C ). This suggested that CS glycoforms were deposited against a receding gliotic front about the interface. In Ch ase ABCinfused test animals, similar deposits were only barely observable at the distal graft−host interface ( Fig. 1E and G). We took advantage of the finding that GFAP-positive astrocytes in vitro could be induced to deposit a fuzzy, CS56-positive, pericellular matrix ( We tested for the in vivo action of Ch ase ABC infused at 0.5 mm distal to the distal graft-host interface. The activity of the enzyme kept in the infusion pump took 3 weeks to decay to half its initial level (Fig. 3A) . By 2 weeks of infusion with Ch ase ABC, extensive 2B6 immunopositivity was found to extend from the infusion site, both caudally, as far as 1.97 ± 0.21mm, and rostrally, beyond the distal graft−host interface into the graft (Fig. 3B) ; accordingly, the extracellular matrix about the interface was CS56-negative (Fig. 3C ). The proximal graft−host interface and the adjoining rostral cord remained 2B6-negative but the former was intensely CS56-positive ( Fig. 3F and G) , indicating that activity due to the infused chondroitinase did not extend as far as the proximal interface. In the vehicle-infused controls, the distal interface and adjoining caudal host cord were, however, 2B6-negative (Fig. 3D ) but CS56-positive (Fig. 3E) . The results indicated that the in vivo activity of the infused enzyme was effective in digesting away extracellular CS glycoforms at the distal graft−host interface and the adjoining caudal cord.
Axonal re-entry into the caudal host cord was enhanced
At the 4th week post-treatment, the contralateral intact hemicord was transected to allow unequivocal tracing of BDA-labeled, regenerating axons from the rostral host cord through the graft into the caudal host cord. Among rats that received Ch ase ABC, 7/12 showed that BDAlabeled axons had successfully re-entered the caudal host cord as far as 5 mm into the gray matter (mean±SD; 3.18±0.98mm, n=7) (Fig. 4A−D) . Horizontal sections of Ch ase ABC-treated cords revealed a mean of 156 regenerating axons (n=3) crossing the distal graft−host interface. In contrast, in vehicle-infused rats (n=12), regenerating axons either skirted the distal graft−host interface or turned back into the graft interior at the interface as shown also by Xu et al. (2, 3) . Immunostaining of Ch ase ABC-treated cords for neurofilament found NF200-positive entanglement at the proximal graft−host interface, discontinuous with NF200-positive axons in the graft (Fig. 4E ). This contrasted with the continuity of NF200-positive axons across the distal interface (Fig. 4F) .
Extent of cavitation and infiltration of activated macrophages was reduced
In all thoracic cords grafted with the SC/MG minichannel, cavitations were observable in the host tissue at both the proximal and distal graft−host junctions, similar to those shown in Fig. 5A and B and as described previously (2, 3, 24) . Caudal host cords that received Ch ase ABC infusion, however, indicated significant reduction in the extent of cavitation (n=3, P<0.02), estimated at 45% of that which received vehicle infusion (Fig. 5C ). Activated macrophages/microglia indicated by ED1-immunopositivity were found dispersed at and beyond the distal graft−host junction, fewer in cases that received Ch ase ABC infusion (49.25±16.94, n=4; Fig. 1H ) than those that received vehicle infusion (mean=152; Fig. 1D ). Secondary damage due to invasion of activated macrophages was therefore diminished.
Astrocytes crossed the distal graft-host interface
In animals that received vehicle infusion, GFAP-positive astrocytes formed an intensifying front on the host side of the graft−host interface, indicative of intense astrogliosis (Fig. 1B) . In animals that received Ch ase ABC infusion, such a GFAP-positive front was much less intense (Fig. 1F) . In addition, GFAP-positive astrocytes apparently advanced from the distal graft−host interface into the graft tissue ( Fig. 1F and G) . Fig. 1E and  3G ). This contrasted with the Ch ase ABC-susceptible CS56-positive margin at the distal graft−host interface and the adjoining caudal cord tissue (Fig. 1A and C) . To find whether the MG matrix of the graft was a source of CS56-positive components, Western blot analysis was performed. Indeed, heterodisperse CS56-positive components (50−85kDa; Fig. 6A, lane 1) were not completely digestible by Ch ase ABC (Fig. 6A, lane 3) , possibly a result of MG gelation at 37°C. Acidification and subsequent neutralization of MG prevented gelation with no loss in CS56 epitopes (Fig. 6A, lanes 1 vs. 2) . The resultant liquid form allowed access of the CS56 epitopes to complete digestion by the enzyme (Fig. 6A, lanes 3 vs. 4) . The results suggested that supramolecular interactions in the gel form limited access of the enzyme to CS56-positive components of the graft tissue. To find if SCs were also a source of CS56-postive components of the graft tissue, SCs were cultured on an MG-coated substratum. Although SCs marked by S100 immunopositivity were found to be CS56-negative, the pericellular CS56-immunopositivity was higher than that of the surrounding MG ( Fig. 6B and C) . SCs could therefore add to the CS-rich environment of MG.
Axonal growth and myelination within the regenerated tissue cable were enhanced
Our observation of a regenerated tissue cable contiguous with the rostral and caudal stumps of the hemisected cord ( Fig. 5A and B) was evidence of success in grafting of an SC/MG channel into the hemisection gap. Cross sections of the regenerated tissue cable that formed in recipients of Ch ase ABC infusion showed widespread fascicles of myelinated axons (Fig. 7E) . EMs of such sections revealed that the regenerated axons were either myelinated or ensheathed by SCs and that these axon-SC units were arranged in fascicles subtended by cell layers in perineurium-like arrangement (Fig. 7F ). This tissue organization was evidently supportive of the abundance of myelinated axons that coursed through the cable (Fig. 7G) . In contrast, cross sections of tissue cables of the vehicle-infused controls showed loose fascicular organization with significantly fewer myelinated axons and varied axonal diameters ( Fig. 7B and C) . As vascularization and cross-sectional area of the tissue cables did not differ between enzyme and vehicle infusion (n=5; Fig. 7H and I), these aspects were apparently unrelated to the enzyme-induced tissue organization of the cable.
DISCUSSION
We present evidence that CS moieties deposited at the gliotic front of the distal graft−host interface constituted a molecular barrier to axonal advancement into the caudal host cord and its removal by the action of infused Ch ase ABC in vivo was a means to diminish the barrier effect (Fig. 8) . This timely removal of CS glycoforms not only improved the interface environment for axonal exit from the regenerated tissue cable into the host cord, but also supported tissue reorganization within the cable. The observed axonal regrowth not only confirmed earlier success in guiding regrowing axons from the rostral host cord into the length of the regenerated tissue cable (3), but also added the new dimension of facilitating exit of these axons into the caudal host cord.
Cellular sources of CS56-positive glycoform deposits
We observed a fuzzy zone doubly positive for CS56 and GFAP alongside the buildup of reactive astrocytes at the distal graft−host interface in vehicle-infused animals. This is reminiscent of the zone of decreased GFAP-reactivity, which was observed in an early phase of CNS injury and was found to persist into later gliosis when reactive astrocytes accumulated (31) . Indeed, filament-rich astrocytic processes were reported to cross the interface, associating with axons and bordering on lesion cavities (3, 17, 32) . At the interface, production of CSPGs could have been increased when astrocytes interfaced with Schwann cells (33) . Macrophages that later infiltrated into the distal interface may well have secreted soluble factors that triggered withdrawal and exile of astrocytes (14) . Some of these factors are likely candidates that stimulate astrocytic production of CSPGs at the gliotic front (34, 35) . At sites of CNS injury, CS-bearing PGs identified with reactive glia include neurocan and phosphacan produced by astrocytes (15, 17) , as well as NG2, neurocan and phosphacan produced by oligodendrocyte precursor cells and macrophages (36) . The relative importance of the different core protein domains and their CS substituents to the axon-restrictive property of the gliotic front is a subject of current investigation (37) . Our results, however, bear out that CS glycoforms produced at the gliotic front constitute a molecular impediment to axonal advancement. (22) , the continuous, microregulated delivery paradigm used in the present work is a step toward automated, focused delivery without at the same time undue hydraulic and mechanical disturbance to the tissue environment (38) . This was clearly reflected by the intact morphology of the cord tissue about the infusion site.
Accessibility of CS56-positive components to
Although a vehicle buffer was used as a control for the bacterial enzyme in our protocol, previous works by Tona and Bignami (39) and Moon et al. (40) demonstrated that growth of severed CNS axons was limited in cases of intracerebral, perilesional administration of either a bacterial enzyme (Streptomyces hyaluronidase) or a mammalian counterpart (bovine testicular hyaluronidase). However, with similar techniques, Moon et al. (21) demonstrated that perilesional administration of Ch ase ABC enhanced regeneration of cut dopaminergic nigral axons through the lesion environment back to the original targets. Axon growth through the lesion environment is evidently due more to CS degradation by the bacterial chondroitinase than to tissue reaction to nonmammalian proteins.
Because little, if any, newly synthesized CS was detectable at the distal interface at the end of our 5-week experimental period, Ch ase ABC activity that lasted at least 3 weeks of infusion was sufficient to clear CS in the vicinity of the distal interface. However, the enzyme had limited access to CS56 epitopes in the graft tissue, possibly due to complex, supramolecular interactions among MG components (41) in the gel form at 37°C. We found that acidification and subsequent neutralization prevented gelation and allowed the epitope to be completely digested by the enzyme. Although CS-bearing perlecan (≈400kDa; 42), bamacan (≈190kDa; 42), leprecan (100kDa; 43) or small basement membrane CSPGs (44) were reported in the EHS sarcoma matrix from which MG was prepared, it was unclear if any of these had been degraded in the extraction and handling procedure to result in the CS56-positive 50−85kD components that we identified in MG.
Axons grow through the regenerated tissue cable and into the caudal host cord
We observed that regrowing axons were ensheathed or myelinated by the grafted SCs as they made their way through the CS-enriched graft environment, contributed largely by MG. Indeed, MG contains such growth factors as IGF-1 and PDGF (45), which support not only the survival of SCs (46, 47) but also the differentiation of fascicles of axon-SC units within the graft environment (3, 17) . We reasoned that regrowing axons that skirted the CS barrier in our vehicle-infused animals were unaccompanied by SCs as they negotiated the CS barrier at the distal graft−host interface. Our observations of regrowing axons in the caudal host cord indicated that regrowing axons could advance through the diminished CS barrier at the interface as a result of Ch ase ABC treatment. As CS is microheterogeneous in O-sulfation and the O-sulfated residues that constitute the domain that is immunoreactive to CS56 are poorly defined, it remains possible that not all CS glycoforms share the same property and only those deposited under gliosis are selectively restrictive to axonal growth. It is however worth noting that all CS glycoforms are susceptible to Ch ase ABC action. The enzyme activity would therefore inadvertently remove any selectivity conferred by combinations of specific CS glycoforms at the distal interface.
The diminished CS barrier at the gliotic front of Ch ase ABC-infused animals apparently supported astrocyte entry into the graft and macrophage dispersal from the distal graft−host interface. Our results further suggested that astrocyte entry into the regenerating tissue cable supported preservation of SC-myelinated axons within fascicular organizations of the cable. Although cystic cavitation is primarily related to macrophage infiltration and inflammation (14, (48) (49) (50) , the dispersal of ED1-immunopositive cells at the Ch ase ABC-treated distal graft−host interface, in correlation with the decreased extent of cavitation, suggests subdued secondary injury on regrowing axons that approached and crossed the interface. We expect growing ends of ascending fibers that reach the interface following digestive removal of the CS barrier can also cross the distal interface into the transplant and thus contribute to the changed tissue organization at both the interface and the regenerating tissue cable.
In the regenerating tissue cable, regenerating axons of enzyme-treated animals tended to show axonal diameters larger than those of vehicle-treated animals but myelin thickness did not seem to differ between the two animal groups. Chondroitinase treatment apparently fostered a graft environment that was conducive to the increase in axonal diameter at a rate that was unmatched by that of myelination by SCs. Given the survival time required for regenerating axons to attain full myelination, animals treated with chondroitinase can possibly achieve myelin thickness commensurate with diameters of the regenerated axons.
In Ch ase ABC recipients, we found regenerating axons as far as 5 mm beyond the distal interface into the gray matter of the caudal host cord. This is comparable to the extent (6mm) achieved with continuous infusion of BDNF and/or NT-3 to the distal junction over a similar period (26) .
Despite profuse axonal growth across the interface, the fibers became hypertrophic and mainly surrounded the infusion site (26) . Our strategy of digestive removal of loose CS deposits at the interface offers the alternative of improving permissiveness of the interface environment for advancing axons to cross into the caudal host cord. In the absence of exogenous neurotrophic support, only propriospinal axons were able to re-establish axons across the graft (2, 3, 24, 51) . Propriospinal inputs sufficed to sustain reflexive and voluntary control of posture and locomotion (52, 53) and contributed to functional recovery in rats following spinal cord lesion (1) . With exogenous neurotrophins, supraspinal and propriospinal inputs could be re-established together with improved functional recovery (10, 11, 26, (54) (55) (56) . Taken together, the results suggest the prospect of combination treatment of the distal interface with Ch ase ABC to remove the inhibitory CS and exogenous neurotrophins to restore supraspinal inputs across the graft and thus to improve chances of functional reconnections within the caudal host cord. This is the first study to demonstrate successful combination of Ch ase ABC treatment with SC grafts into the midthoracic hemisected spinal cord of adult rats. Although the enzyme had been used to treat lesioned CNS tissues in experimental animals (20, 21, 23) , the lesions induced in the reported studies were considerably smaller than the hemisection gap in our current model. Indeed, gaps or cavities inevitably occur in patients who have spinal cord injuries (57) (58) (59) and thus the SC-bridge is a promising strategy to promote axonal regrowth across the lesion gap. With Ch ase ABC infusion to the distal graft−host interface, the prospect of the therapeutic use of the SC-seeded guidance channel as a bridge to facilitate axonal regrowth across the site of traumatic injury in the spinal cord is advanced. In vehicle-infused controls, a fuzzy CS56-positive zone (region within arrows; A−C and insets) was juxtaposed between an intensely CS56-positive matrix of the graft tissue and a front of GFAP-positive astrocytes in the caudal host cord; ED1-positive macrophages/microglia ( ; D and inset) were also gathered at the graft−host interface. In recipients of Ch ase ABC infusion, the fuzzy CS56-positive zone was significantly diminished (region within arrows; E and inset); some GFAP-positive astrocytes apparently left the caudal host front to enter the graft side (∆; F, G, and insets), whereas ED1-positive macrophages/microglia ( ; H and inset) dispersed into both graft and host sides of the interface. Scale bars, 100 µm (A−C, E−G), 50 µm (D, H; insets in A−C, E−G), 12.5 µm (insets in D, H) . Digital images were adjusted for brightness and contrast. , D) show the stellate morphology and extended processes (↑) of serum-starved astrocytes in vitro. Under fluorescence microscopy, the same cells were GFAP-positive (B, E) and pericellular deposits were CS56-positive (C). Pericellular CS56-immunoreactivity became nonapparent after Ch ase ABC treatment (F); overexposure of (F) in the photographic procedure, however, brought out the cell body and processes that otherwise remained dark. Scale bar, 10 µm (A−F). Photomicrographs (B-D) of horizontal sections corresponding to regions B, C, and D are shown below the drawing. In (C), the graft is to the left of the dashed line, and the caudal host cord is to the right. Axons (∆) that skirted the interface on the graft side did not advance into the caudal cord; other axons ( ) succeeded in crossing the interface into the caudal cord. In (D), some axons in the gray matter of the caudal cord were in close proximity to neuronal cell bodies (*) that apparently had been labeled with BDA. In (E), immunostaining for NF200 revealed entanglement of fibers at the proximal graft−host interface, discontinuous with immunopositive fibers in the graft. This contrasted with the continuity of regrowing axons across the distal interface (F). Scale bars, 500 µm (A), 50 µm (B, C), 25 µm (D), 100 µm (E, F). Although the S100-positive SC (∆) was CS56-negative, the pericellular CS56-immunopositivity, more intense than the surrounding MG, suggests secretion by the SC. Scale bar, 100 µm (B−D). In vehicle-infused controls, regrowing axons skirt the distal interface where deposits of CS56-positive glycoforms were found to build up among ED1-positive macrophages/microglia against a front of reactive astrocytes. As Ch ase ABC infusion clears away CS56-positive glycoforms, macrophages/microglia disperse, astrocytes migrate into the regenerating tissue cable, and regrowing axons can negotiate across the interface into the caudal host cord. The dashed outline marks the boundary of a CS56-negative but 2B6-positive zone corresponding to the CS56-positive deposit in the vehicle-infused controls.
